Atan Gross

Left to right: Dr. Atan Gross, Iris Kamer, Dr. Rachel Sarig, Limor Regev, Galia Oberkovitz, Dr. Hagit Niv and Dr. Yehudit Zaltsman. Cellular self-check

02.10.2005

Biochemistry, Cancer, Molecular and Cell Biology, Genetics

One protein is recruited to aid in both cell death and survival

TAKING ACTION AT STEP 2: TUMOR GROWTH

TAKING ACTION AT STEP 2: TUMOR GROWTH

01.09.2004

Space & Physics, Biochemistry, Brain & Behavior, Cancer, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Genetics, Structural Biology

Even after a malignant transformation has occurred, the budding tumor is a microscopic lump that doesn’t do much harm until...

Dr. Atan Gross.

Death of a Cell

01.05.2002

Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics

There is a fine line between life and death in the microscopic world of the cell

Pages

Top Stories

Magnetic resonance imaging (MRI) scans of the brain in three children with a missing copy of the Chaserr gene. The scans performed at age 8 months or 4 years (top row) reveal structural changes in the brain, including reduced volume of the brain stem (asterisks) and decreased myelin coating of nerves (arrows) in deep-seated brain areas. These changes are less apparent at 1 month of age (bottom row)

Emma’s Gene

Faster, Smarter, More Open: A New Way to Accelerate AI Models

The Human Phenotype Project

Meet Your Digital Twin

The Dark Side of Time

Press Releases

Faster, Smarter, More Open: A New Way to Accelerate AI Models

Meet Your Digital Twin

A New Blood Test May Detect Leukemia Risk and Replace Bone Marrow Sampling

Most Popular Articles

One Protein, Two Programs

A cell’s decision to commit suicide involves an exchange of information between two suicide mechanisms

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Checking the Dosage

Prof. Yoram Groner is a pioneer in Down syndrome research